Back

Implant-based isolation of pulmonary veins

29 August 2016 (11:50 - 12:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation ablation: novelties and advances Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Glenn Van Langenhove

General hospital Maria Middelares, Gent (Belgium)

8 More presentations in this session

Presentation thumbnail
Impact of continuous monitoring of the pulmonary venous pressure on the acute results of cryoablation: A derivation and validation study.
Doctor K. Hasegawa (Fukui, JP)
Abstract Slides Video
Presentation thumbnail
Importance of non-pulmonary vein triggers in patients with high baseline fasting blood sugar undergoing catheter ablation for atrial fibrillation
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Durability of pulmonary vein isolation by various kind of ablation catheter
Doctor A. Kobori (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Cryoablation for persistent atrial fibrillation in comparison with open-irrigated radiofrequency technique: preliminary results of a randomised clinical trial
Doctor M. Gallagher (London, GB)
Abstract Slides Video
Presentation thumbnail
Linear ablation following pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis
Doctor T. Liu (Tianjin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation: novelties and advances

The Event

Event poster

ESC Congress 2016

29 August 2016 11:50 CET
You may be interested in
thumbnail
Congress Presentation
Pulmonary vein isolation by irreversible electroporation: an efficacy and safety study in 20 patients with atrial fibrillation
25 April 2021
thumbnail
Congress Presentation
Association of superior vena cava isolation with improved outcomes in atrial fibrillation ablation
8 April 2024
thumbnail
Congress Session
Live-in-the-Box - treating atrial fibrillation beyond PVI
1 April 2025
thumbnail
Congress Session
Pulsed field ablation: advancing safety, durability, and efficiency in atrial fibrillation treatment
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources